Skip to main navigation Skip to search Skip to main content

An Evaluation of the Metabolic Effects of Exenatide, Rosiglitazone, and Exenatide Plus Rosiglitazone in Subjects with Type 2 Diabetes Mellitus Treated with Metformin

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date08/12/05 → 08/31/09

Funding

  • Eli Lilly and Company: $45,051.10